These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23489141)

  • 1. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
    Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
    Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
    Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    Galindo-Tovar A; Kaumann AJ
    Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart.
    Christ T; Galindo-Tovar A; Thoms M; Ravens U; Kaumann AJ
    Br J Pharmacol; 2009 Jan; 156(1):62-83. PubMed ID: 19133992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of cardiac beta1- and beta2-adrenoceptors of newborn piglets: role of phosphodiesterases PDE3 and PDE4.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Eur J Pharmacol; 2010 Jul; 638(1-3):99-107. PubMed ID: 20406625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
    Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterases do not limit beta1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats.
    Kaumann AJ; Galindo-Tovar A; Escudero E; Vargas ML
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):421-30. PubMed ID: 19693491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium.
    Christ T; Engel A; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):249-53. PubMed ID: 17106669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE4 in the human heart - major player or little helper?
    Eschenhagen T
    Br J Pharmacol; 2013 Jun; 169(3):524-7. PubMed ID: 23489196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
    Kaumann A; Semmler AB; Molenaar P
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):123-31. PubMed ID: 17318500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
    Orstavik O; Ata SH; Riise J; Dahl CP; Andersen GØ; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2014 Dec; 171(23):5169-81. PubMed ID: 24547784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):379-84. PubMed ID: 19005642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
    Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
    Vargas ML; Hernandez J; Kaumann AJ
    Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Molenaar P; Christ T; Ravens U; Kaumann A
    Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase PDE2 activity, increased by isoprenaline, does not reduce β-adrenoceptor-mediated chronotropic and inotropic effects in rat heart.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun; 391(6):571-585. PubMed ID: 29556684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.
    Heubach JF; Rau T; Eschenhagen T; Ravens U; Kaumann AJ
    Br J Pharmacol; 2002 May; 136(2):217-29. PubMed ID: 12010770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
    Hussain RI; Aronsen JM; Afzal F; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
    J Mol Cell Cardiol; 2013 Mar; 56():129-38. PubMed ID: 23220156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.